Introduction
REVOLAX is a hyaluronic acid (HA) dermal filler range widely used in UK aesthetic clinics for facial volume restoration and structural contouring. Developed by Across Co. Ltd., it is designed for professional injection use across multiple facial planes, offering predictable tissue integration and consistent rheological performance. Within the UK medical aesthetics market, it is positioned as a reliable HA filler suitable for both beginner and experienced injectors working in clinic-based aesthetic practice.
REVOLAX a Brand Overview
REVOLAX is a monophasic, cross-linked hyaluronic acid gel designed to provide structural support with a smooth, uniform consistency. The formulation is based on high-purity HA with a highly cross-linked network, intended to maintain shape stability after injection while still allowing controlled tissue integration.
The range typically includes REVOLAX Fine, REVOLAX Deep, and REVOLAX Sub-Q, each designed for different injection depths and clinical indications. REVOLAX Fine is generally used for superficial fine lines and perioral refinement, while REVOLAX Deep is more commonly selected for mid-dermal volumisation such as nasolabial folds and marionette lines. REVOLAX Sub-Q is the highest viscosity option, typically used for deeper structural augmentation including cheeks, chin, and jawline contouring.
The manufacturer states the gels are monophasic in structure, allowing smooth extrusion and consistent placement during injection. Lidocaine-containing formulations (0.3%) are available in many variants, supporting patient comfort during treatment. In clinical practice, practitioners often value the product’s balance between projection and mouldability, particularly in mid-to-deep dermal applications where control and predictability are important.
Overall, REVOLAX is commonly integrated into full-face aesthetic treatment plans, particularly where structured volumisation and soft tissue support are required without excessive diffusion.
REVOLAX Price is it worth it for your clinic? Lets See!
In the UK aesthetic market, REVOLAX is typically positioned in the mid-range category. Clinic purchase prices generally fall between £55–£90 per 1ml syringe depending on supplier, volume discounts, and product variant (Fine, Deep, or Sub-Q).
Several factors influence overall cost. Product viscosity and intended indication play a major role, with higher-density gels such as Sub-Q generally sitting at the upper end of the price range due to their structural application. HA concentration and crosslinking density also contribute to manufacturing complexity and pricing structure, particularly where increased durability and lift capacity are required.
Practitioner experience is another consideration. While REVOLAX is widely used across a broad range of injectors, optimal outcomes depend on correct product selection and anatomical placement. Treatment longevity and consistency are often factored into clinic pricing models, especially when planning full-face volumisation or combination treatment protocols.
Within UK clinics, REVOLAX is generally viewed as a cost-effective, reliable HA filler range that supports a wide variety of indications without positioning itself as a premium or entry-level-only option. Its versatility across multiple facial layers makes it a practical choice for clinics managing diverse patient needs and treatment plans.
Buy REVOLAX Online Buy Now Buy Today!
Medical professionals looking to buy REVOLAX online in the UK require assurance of authenticity, regulated supply, and consistent delivery for clinical use. At SkinOnYou.com, clinics can source professional-use dermal fillers suitable for licensed aesthetic practice, including the full REVOLAX range.
Available variants typically include REVOLAX Fine, REVOLAX Deep, and REVOLAX Sub-Q, allowing practitioners to select the appropriate product based on treatment depth and indication. All products are intended for professional administration only and should be used by trained medical practitioners familiar with facial anatomy and injectable techniques.
Clinics often prioritise authenticated supply chains, particularly when sourcing HA fillers for routine aesthetic procedures such as lip augmentation, mid-face volumisation, and jawline definition. Fast UK delivery and verified stock help ensure continuity of clinical operations and patient scheduling.
Whether sourcing REVOLAX for ongoing clinic demand or establishing a consistent injectable portfolio, practitioners benefit from reliable access to genuine products designed for aesthetic injection use only. As demand continues across UK aesthetic medicine, REVOLAX remains a widely used HA filler range supported by its versatility and ease of clinical integration.